Objectives. To examine the association between parental human papillomavirus (HPV) awareness and HPV vaccine initiation/completion based on 13-to 17-year-old US adolescent children and to explore whether these associations were mediated by provider recommendation. Methods. We used publicly available National Immunization Survey-Teen 2011 data (11 236 adolescent girls and 12 328 boys). Results. Weighted logistic regression analysis showed that parental HPV awareness and provider recommendation predicted HPV vaccine initiation and completion separately among both girls and boys, after adjusting for demographic and health care use variables. When provider recommendation and parental HPV awareness were entered in the model simultaneously, only provider recommendation was independently associated with HPV vaccine initiation and completion, demonstrating a mediation effect of provider recommendation. Conclusions. Future studies are needed to better understand why physicians may not provide a recommendation for the HPV vaccine as well as to identify strategies to improve providers' ability to effectively communicate their recommendations.
Introduction
Human papillomavirus (HPV) is responsible for almost all cervical cancers and 90% of genital warts as well as a substantial number of other anogenital and head and neck cancers. [1] [2] [3] [4] The HPV vaccine can protect against 70% of cervical cancer cases and 90% of genital warts. 2, 5 However, nationally representative data from 2011 showed that HPV vaccine uptake (≥1 dose) among 13to 17-year-old girls (53%) and boys (8%) was much lower than that for other vaccines administered to this age group (Tdap, 78%; meningococcal, 71%). 6 Parental HPV vaccine awareness, parental acceptability, and provider recommendation are key factors for higher HPV vaccine uptake among adolescents. [7] [8] [9] [10] [11] Yet HPV vaccine uptake in adolescent girls has not substantially increased over time although parental awareness has increased. 6, 12, 13 There is a need to understand how parental HPV vaccine awareness affects vaccine initiation and completion and whether vaccine uptake is mediated by other factors. The objective of this study was to examine the association between parental HPV vaccine awareness and vaccine initiation/completion among 13-to 17-year-old US adolescents and to explore whether these associations were mediated by provider recommendation.
Methods
The National Immunization Survey-Teen (NIS-Teen), conducted by the Centers for Disease Control and Prevention, is a continuous cross-sectional survey of provider-verified vaccination information on 13-to 17-year-old US adolescents. NIS-Teen methodology has been reported elsewhere. 14 Household interviews for 39 839 teens were conducted in 2011, of which 23 564 had provider-verified HPV vaccination information (excluding U.S. Virgins Islands).
We considered provider-verified HPV vaccine initiation (received at least 1 dose of HPV vaccine) or completion (received ≥3 doses of HPV vaccine) as the dependent variable, parental HPV vaccine awareness as an independent variable, and provider recommendation as a mediator variable. Parental HPV vaccine awareness was assessed using the question, "Have you ever heard of the cervical cancer vaccine, HPV shot, or Gardasil?" The response options were the following: "yes," "no," "don't know," and "refused." Those who responded "yes" were considered as having HPV vaccine awareness. Information on whether the participant had provider recommendation for the HPV vaccine was obtained using the following question, with similar response options: "Had or has doctor or other health care professional ever recommended that teen receive HPV shots?" Similarly, information on the total number of HPV vaccine doses received was obtained. Sociodemographic characteristics included information about the teen, mother, and household. Respondents provided data on their age as well as their relationship to the adolescent (mother, father, other) and the adolescent's age, race/ ethnicity, eligibility for the Vaccine for Children program, influenza vaccination before age 13 years, health care coverage, and region of residence.
Statistical Analysis
STATA 12 svy commands (StataCorp, College Station, TX) were used for data analysis by incorporating probability sampling weights in conjunction with strata and primary sampling units generated by the NIS-Teen survey design. We used logistic regression models to examine the mediation effect of the mediator variable on the association between the independent variable and dependent variable based on standard criteria 15, 16 : (1) statistically significant relationship between the independent variable and dependent variable, (2) statistically significant relationship between the independent variable and mediator variable, (3) existence of a significant effect of the mediator variable on the dependent variable in the presence of the independent variable, and (4) diminishing magnitude of the effect of the independent variable on the dependent variable when the mediator variable is controlled. All multivariable models were adjusted for sociodemographic covariates.
Results
Provider-verified HPV vaccination data were available for 11 236 adolescent girls and 12 328 boys. Overall, 53.0% (95% confidence interval [CI] = 51.4-54) and 34.8% (95% CI = 33.2-36.4) of girls (weighted values) reported initiating and completing the 3-dose series in 2011, respectively ( Table 1 ). The respective figures for boys were 8.3% (95% CI = 7.4-9.3) and 1.3% (95% CI = 1.1-1.7). In all, 90% of parents with a girl and 81.5% of parents with a boy were aware of the HPV vaccine, whereas 58.8% and 14.2%, respectively, reported that their provider had recommended this vaccine for their child. Distribution of sociodemographic variables was comparable between respondents with a girl and a boy (P > .05 for all comparisons).
We summarized mediation analyses in Figure 1 . Adjusted logistic regression analyses showed that parental HPV vaccine awareness and provider recommendation separately predicted HPV vaccine initiation and completion among girls and boys. However, when they were entered in the logistic models simultaneously, only provider recommendation independently predicted vaccine initiation and completion, demonstrating a mediation effect of provider recommendation. Moreover, changes in odds ratio from statistically significant to statistically nonsignificant indicated the presence of full mediation.
Discussion
Published reports show that both parental HPV vaccine awareness and provider recommendation are strong predictors of HPV vaccine uptake. [7] [8] [9] [10] [11] However, the mechanism through which they increase vaccine uptake is not understood. This study observed that provider recommendation mediated the association between parental HPV vaccine awareness and HPV vaccine initiation and completion.
Although HPV vaccine awareness has reached 90% and 82% among parents with an adolescent girl or boy in 2011, respectively, the rates of HPV vaccine uptake have remained stagnant. This suggests that other factors may play an important role in translating parental HPV vaccine awareness into vaccine uptake. On the other hand, only 59% and 14% of parents reported that they had ever received a provider recommendation to vaccinate their adolescent girls and boys, respectively. However, very low provider recommendation for adolescent boys might be a result of the fact that the Advisory Committee on Immunization Practices recommendation for the use of quadrivalent HPV vaccine in males was made in October 2011. This situation reveals that there is much room available to improve provider recommendation for this vaccine. Because we observed that provider recommendation is actually a mediator of the association between HPV vaccine awareness and HPV vaccine uptake, irrespective of gender, there are reasons to believe that improvement in provider recommendation would improve HPV vaccine initiation and completion. It is also important to examine barriers to provider recommendation for this vaccine in future studies because almost half of the respondents with a girl and 7 out of 8 respondents with a boy mentioned that they did not get provider recommendation for this vaccine. Many physicians believe that parental refusal is an important barrier because they ignore physician recommendation. Future studies are also needed to better understand why physicians may not provide a recommendation for the HPV vaccine as well as to identify strategies to improve the provider's ability to effectively communicate their recommendation.
Conclusion
The results of this study, based on nationally representative data from the United States, demonstrate the importance of incorporating provider recommendation into all programs promoting HPV vaccine uptake in adolescent children. In addition, studies to identify barriers to effective communication between providers and parents of eligible children are also needed. Increasing provider recommendations for the HPV vaccine may help increase HPV vaccine initiation and completion rates among adolescent children in the United States.
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Steps for a mediation effect 15, 16 Table 1 and based on weighted analysis.
